Adagio Therapeutics (ADGI) Short Interest Ratio & Short Volume → This company has increased its dividend every year for 54 years (From DTI) (Ad) Free ADGI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Adagio Therapeutics Short Interest DataCurrent Short Volume4,050,000 sharesPrevious Short Volume4,650,000 sharesChange Vs. Previous Month-12.90%Dollar Volume Sold Short$0.00Short Interest Ratio / Days to Cover6.7Last Record DateSeptember 15, 2022Outstanding Shares108,831,000 sharesFloat Size36,290,000 sharesShort Percent of Float11.16%Today's Trading Volume22,357 sharesAverage Trading Volume2,269,922 sharesToday's Volume Vs. Average1% Short Selling Adagio Therapeutics ? Sign up to receive the latest short interest report for Adagio Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatADGI Short Interest Over TimeADGI Days to Cover Over TimeADGI Percentage of Float Shorted Over Time Ad Paradigm PressBitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. Adagio Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/20224,050,000 shares $0.00 -12.9%11.2%6.7 $0.00 8/31/20224,650,000 shares $21.20 million +26.7%12.8%6.6 $4.56 8/15/20223,670,000 shares $14.64 million -13.2%9.3%4.6 $3.99 7/31/20224,230,000 shares $14.89 million +7.9%10.7%5.2 $3.52 7/15/20223,920,000 shares $15.76 million -3.0%9.9%4 $4.02 6/30/20224,040,000 shares $13.25 million -7.8%10.3%3.5 $3.28 6/15/20224,380,000 shares $11.52 million -6.6%11.1%1.5 $2.63 5/31/20224,690,000 shares $13.88 million +20.3%11.9%1.6 $2.96 5/15/20223,900,000 shares $10.61 million -21.4%9.9%1.2 $2.72 4/30/20224,960,000 shares $14.19 million -14.0%12.6%1.4 $2.86 4/15/20225,770,000 shares $20.71 million +7.9%14.6%1.5 $3.59 3/31/20225,350,000 shares $24.40 million +1.1%13.0%1.2 $4.56 3/15/20225,290,000 shares $25.02 million +0.2%12.9%1.5 $4.73 2/28/20225,280,000 shares $35.32 million -11.7%12.9%0.6 $6.69 2/15/20225,980,000 shares $42.52 million -25.4%14.6%0.7 $7.11 1/31/20228,020,000 shares $57.58 million +12.8%19.8%1 $7.18 1/15/20227,110,000 shares $40.53 million -1.5%17.6%0.9 $5.70 12/31/20217,220,000 shares $52.42 million No Change17.9%1 $7.26 ADGI Short Interest - Frequently Asked Questions What is Adagio Therapeutics' current short interest? Short interest is the volume of Adagio Therapeutics shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 4,050,000 shares of ADGI short. 11.16% of Adagio Therapeutics' shares are currently sold short. Learn More on Adagio Therapeutics' current short interest. What is a good short interest ratio for Adagio Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADGI shares currently have a short interest ratio of 7.0. Learn More on Adagio Therapeutics's short interest ratio. What is a good short interest percentage for Adagio Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.16% of Adagio Therapeutics' floating shares are currently sold short. Is Adagio Therapeutics' short interest increasing or decreasing? Adagio Therapeutics saw a decline in short interest in September. As of September 15th, there was short interest totaling 4,050,000 shares, a decline of 12.9% from the previous total of 4,650,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Adagio Therapeutics' float size? Adagio Therapeutics currently has issued a total of 108,831,000 shares. Some of Adagio Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Adagio Therapeutics currently has a public float of 36,290,000 shares. How does Adagio Therapeutics' short interest compare to its competitors? 11.16% of Adagio Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Adagio Therapeutics: Voyager Therapeutics, Inc. (6.13%), C4 Therapeutics, Inc. (13.34%), Taysha Gene Therapies, Inc. (9.08%), iTeos Therapeutics, Inc. (7.19%), Valneva SE (0.07%), Replimune Group, Inc. (17.40%), Jasper Therapeutics, Inc. (3.84%), Ocugen, Inc. (16.95%), Solid Biosciences Inc. (3.05%), Editas Medicine, Inc. (20.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($4.11 billion), Canadian Natural Resources Limited ($3.64 billion), Charter Communications, Inc. ($3.15 billion), Lucid Group, Inc. ($2.09 billion), Chesapeake Energy Co. ($2.02 billion), Coinbase Global, Inc. ($2.01 billion), T. Rowe Price Group, Inc. ($1.92 billion), Plug Power Inc. ($1.77 billion), Rivian Automotive, Inc. ($1.71 billion), and Williams-Sonoma, Inc. ($1.59 billion). View all of the most shorted stocks. What does it mean to sell short Adagio Therapeutics stock? Short selling ADGI is an investing strategy that aims to generate trading profit from Adagio Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adagio Therapeutics? A short squeeze for Adagio Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADGI, which in turn drives the price of the stock up even further. How often is Adagio Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADGI, twice per month. The most recent reporting period available is September, 15 2022. More Short Interest Resources from MarketBeat Related Companies: Voyager Therapeutics Short Squeeze C4 Therapeutics Short Squeeze Taysha Gene Therapies Short Squeeze iTeos Therapeutics Short Squeeze Valneva Short Squeeze Replimune Group Short Squeeze Jasper Therapeutics Short Squeeze Ocugen Short Squeeze Solid Biosciences Short Squeeze Editas Medicine Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADGI) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchOptions trading has suddenly become more reliable.Eagle PublishingTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsYou won't believe what Citigroup just did to it's depositorsAmerican Alternative